# 2025-04045: DEA Okays Bulk GHB Production for Sleep Disorder Pills?

2025-04045, Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-03-13, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 12, 2025. Such persons may also file a written request for a hearing on the application on or before May 12, 2025. (as of 2026-09-30).

- Canonical: https://policyrisk.com/federal-register/2025-04045
- As of: 2026-09-30
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-04045
- Title: Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 11997
- Published: 2025-03-13
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 12, 2025. Such persons may also file a written request for a hearing on the application on or before May 12, 2025.
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-09-30

## In one line

DEA Okays Bulk GHB Production for Sleep Disorder Pills?

## Summary

Patheon Pharmaceuticals wants to make a special controlled drug called Gamma Hydroxybutyric Acid in large amounts. If approved, they’ll produce it as a key ingredient for FDA-approved medicines. People can share their thoughts or ask for a hearing by May 12, 2025, so keep an eye on that deadline!

## Abstract

Patheon Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-04045 on federalregister.gov](https://www.federalregister.gov/documents/2025/03/13/2025-04045/bulk-manufacturer-of-controlled-substances-application-patheon-pharmaceuticals-inc)
- [2025-04045 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-03-13/pdf/2025-04045.pdf)

## Related
- [Previous: 2025-04044, Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research…](https://policyrisk.com/federal-register/2025-04044)
- [Next: 2025-04046, Importer of Controlled Substances Application: Fisher Clinical Services, Inc.](https://policyrisk.com/federal-register/2025-04046)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-04045 (as of 2026-09-30).
